InsightfulValue
← Home

Takeda Pharmaceutical
Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Takeda Pharmaceutical

πŸ“Š Get full analytics about Takeda Pharmaceutical

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
Takeda Pharmaceutical Company Limited is a global, research-based pharmaceutical company headquartered in Japan. The company was founded in 1781 and has a rich history of over 200 years of continuous operation.
Takeda is one of the world's largest pharmaceutical companies, with a focus on developing and delivering innovative medicines to patients in more than 80 countries and regions around the world. The company's research and development efforts are focused on four therapeutic areas: oncology, gastroenterology, neurology, and rare diseases.
With a commitment to improving the health and well-being of people worldwide, Takeda strives to develop safe and effective medicines to treat a wide range of diseases and conditions. In addition to its core therapeutic areas, the company also has a growing portfolio in vaccines and consumer healthcare.
Takeda's corporate philosophy, "Takeda-ism," emphasizes its dedication to ethical and responsible business practices, as well as its commitment to patients, employees, and the global community.
Today, Takeda has a team of more than 49,000 employees worldwide, and its research and development efforts are led by a diverse network of scientists, researchers, and physicians who collaborate globally to drive innovation and advancement in the pharmaceutical industry.
What is special about the company?
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

VGhlcmUgYX JlIHNldmVy YWwgYXNwZW N0cyB0aGF0 IG1ha2UgVG FrZWRhIFBo YXJtYWNldX RpY2FsIHN0 YW5kIG91dC BhcyBhIGNv bXBhbnk6PG JyPjEuIExv bmcgSGlzdG 9yeTogVGFr ZWRhIFBoYX JtYWNldXRp Y2FsIHdhcy Bmb3VuZGVk IGluIDE3OD EsIG1ha2lu ZyBpdCBvbm Ugb2YgdGhl IG9sZGVzdC Bjb21wYW5p ZXMgaW4gSm FwYW4gYW5k IHRoZSB3b3 JsZC4gVGhp cyBsb25nIG hpc3Rvcnkg aGFzIGFsbG 93ZWQgdGhl IGNvbXBhbn kgdG8gZ2Fp biBleHRlbn NpdmUga25v d2xlZGdlIG FuZCBleHBl cmllbmNlIG luIHRoZSBw aGFybWFjZX V0aWNhbCBp bmR1c3RyeS 48YnI+Mi4g SW50ZXJuYX Rpb25hbCBQ cmVzZW5jZT ogVGFrZWRh IGhhcyBhIH N0cm9uZyBn bG9iYWwgcH Jlc2VuY2Us IHdpdGggb3 BlcmF0aW9u cyBpbiBvdm VyIDgwIGNv dW50cmllcy BhbmQgcmVn aW9ucyB3b3 JsZHdpZGUu IEl0IGhhcy BhIHN0cm9u ZyBmb2N1cy BvbiBlbWVy Z2luZyBtYX JrZXRzLCBl c3BlY2lhbG x5IGluIEFz aWEsIHdoZX JlIHRoZSBj b21wYW55IG hhcyBhIGxl YWRpbmcgcG 9zaXRpb24g aW4gdGhlIH BoYXJtYWNl dXRpY2FsIG luZHVzdHJ5 Ljxicj4zLi BEaXZlcnNl IFBvcnRmb2 xpbzogVGFr ZWRhIGhhcy BhIGRpdmVy c2UgcG9ydG ZvbGlvIG9m IHByb2R1Y3 RzLCBjb3Zl cmluZyBhIH dpZGUgcmFu Z2Ugb2YgdG hlcmFwZXV0 aWMgYXJlYX MsIGluY2x1 ZGluZyBvbm NvbG9neSwg Z2FzdHJvZW 50ZXJvbG9n eSwgbmV1cm 9zY2llbmNl LCByYXJlIG Rpc2Vhc2Vz LCBhbmQgdm FjY2luZXMu IFRoaXMgZG l2ZXJzaWZp Y2F0aW9uIG hlbHBzIHRo ZSBjb21wYW 55IG1pdGln YXRlIHJpc2 tzIGFuZCBt YWludGFpbi BhIHN0YWJs ZSByZXZlbn VlIHN0cmVh bS48YnI+NC 4gSW5ub3Zh dGlvbjogVG FrZWRhIGhh cyBhIHN0cm 9uZyBmb2N1 cyBvbiByZX NlYXJjaCBh bmQgZGV2ZW xvcG1lbnQg KFImRCksIH dpdGggYSBz aWduaWZpY2 FudCBpbnZl c3RtZW50IG luIGN1dHRp bmctZWRnZS B0ZWNobm9s b2d5IGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIGV4 dGVybmFsIH BhcnRuZXJz LiBUaGUgY2 9tcGFueSBh bHNvIGhhcy BhIHJvYnVz dCBwaXBlbG luZSBvZiBw b3RlbnRpYW wgbmV3IHRy ZWF0bWVudH MsIGVuc3Vy aW5nIGl0cy Bsb25nLXRl cm0gZ3Jvd3 RoLjxicj41 LiBDb3Jwb3 JhdGUgU29j aWFsIFJlc3 BvbnNpYmls aXR5OiBUYW tlZGEgaXMg Y29tbWl0dG VkIHRvIGNv cnBvcmF0ZS ByZXNwb25z aWJpbGl0eS BhbmQgaGFz IHNldCBhbW JpdGlvdXMg Z29hbHMgdG 8gcmVkdWNl IGl0cyBlbn Zpcm9ubWVu dGFsIGltcG FjdCBhbmQg aW1wcm92ZS BhY2Nlc3Mg dG8gaGVhbH RoY2FyZSBn bG9iYWxseS 4gVGhlIGNv bXBhbnkgYW xzbyBoYXMg dmFyaW91cy Bwcm9ncmFt cyBpbiBwbG FjZSB0byBz dXBwb3J0IG NvbW11bml0 aWVzIGFuZC Bwcm9tb3Rl IGRpdmVyc2 l0eSBhbmQg aW5jbHVzaW 9uLjxicj42 LiBWYWx1ZX MtRHJpdmVu IEN1bHR1cm U6IFRha2Vk YSdzIGNvcm UgdmFsdWVz LCBzdWNoIG FzICJpbnRl Z3JpdHksIG ZhaXJuZXNz LCBhbmQgaG 9uZXN0eSIg YW5kICJwdX R0aW5nIHRo ZSBwYXRpZW 50IGZpcnN0 LCIgYXJlIG RlZXBseSBp bmdyYWluZW QgaW4gaXRz IGNvcnBvcm F0ZSBjdWx0 dXJlLiBUaG lzIHN0cm9u ZyBldGhpY2 FsIGZvdW5k YXRpb24gZ3 VpZGVzIHRo ZSBjb21wYW 55J3MgZGVj aXNpb24tbW FraW5nIGFu ZCBkcml2ZX MgaXRzIGNv bW1pdG1lbn QgdG8gbWFr aW5nIGEgcG 9zaXRpdmUg aW1wYWN0IG luIHRoZSB3 b3JsZC48Yn I+SW4gY29u Y2x1c2lvbi wgVGFrZWRh IFBoYXJtYW NldXRpY2Fs J3MgbG9uZy BoaXN0b3J5 LCBnbG9iYW wgcHJlc2Vu Y2UsIGRpdm Vyc2UgcG9y dGZvbGlvLC Bmb2N1cyBv biBpbm5vdm F0aW9uLCBj b21taXRtZW 50IHRvIHNv Y2lhbCByZX Nwb25zaWJp bGl0eSwgYW 5kIHZhbHVl cy1kcml2ZW 4gY3VsdHVy ZSBhbGwgbW FrZSBpdCBh IHVuaXF1ZS BhbmQgc3Vj Y2Vzc2Z1bC Bjb21wYW55 IGluIHRoZS BwaGFybWFj ZXV0aWNhbC BpbmR1c3Ry eS4=
What the company's business model?
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIFRha2 VkYSBQaGFy bWFjZXV0aW NhbCBjb21w YW55J3MgYn VzaW5lc3Mg bW9kZWwgaX MgYmFzZWQg b24gcmVzZW FyY2hpbmcs IGRldmVsb3 BpbmcsIG1h bnVmYWN0dX JpbmcsIGFu ZCBtYXJrZX RpbmcgcGhh cm1hY2V1dG ljYWwgcHJv ZHVjdHMuIF RoZSBjb21w YW55IGZvY3 VzZXMgb24g dGhlIGZvbG xvd2luZyBr ZXkgYXJlYX M6PGJyPjEu IFJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudDogVGFr ZWRhIGludm VzdHMgaGVh dmlseSBpbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQgdG8gZG lzY292ZXIg YW5kIGRldm Vsb3AgbmV3 IG1lZGljaW 5lcyBmb3Ig ZGlzZWFzZX Mgd2l0aCBo aWdoIHVubW V0IG1lZGlj YWwgbmVlZH MuPGJyPjIu IE1hbnVmYW N0dXJpbmc6 IFRha2VkYS BoYXMgYSBn bG9iYWwgbm V0d29yayBv ZiBtYW51Zm FjdHVyaW5n IGZhY2lsaX RpZXMgdG8g cHJvZHVjZS BpdHMgcGhh cm1hY2V1dG ljYWwgcHJv ZHVjdHMgYX QgaGlnaCBx dWFsaXR5IG FuZCBlZmZp Y2llbmN5Lj xicj4zLiBN YXJrZXRpbm cgYW5kIHNh bGVzOiBUYW tlZGEgbWFy a2V0cyBhbm Qgc2VsbHMg aXRzIHByb2 R1Y3RzIHRv IGhlYWx0aG NhcmUgcHJv ZmVzc2lvbm FscyBhbmQg cGF0aWVudH MgZ2xvYmFs bHkgdGhyb3 VnaCB2YXJp b3VzIGNoYW 5uZWxzLCBp bmNsdWRpbm cgc2FsZXMg cmVwcmVzZW 50YXRpdmVz LCBkaWdpdG FsIG1hcmtl dGluZywgYW 5kIHBhcnRu ZXJzaGlwcy B3aXRoIGhl YWx0aGNhcm Ugb3JnYW5p emF0aW9ucy 48YnI+NC4g RGl2ZXJzaW ZpY2F0aW9u OiBUYWtlZG EgaGFzIGEg ZGl2ZXJzZS Bwb3J0Zm9s aW8gb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IHJhbmdpbm cgZnJvbSBw cmVzY3JpcH Rpb24gbWVk aWNpbmVzIH RvIG92ZXIt dGhlLWNvdW 50ZXIgYW5k IGNvbnN1bW VyIGhlYWx0 aGNhcmUgcH JvZHVjdHMu PGJyPjUuIE dlb2dyYXBo aWMgZXhwYW 5zaW9uOiBU YWtlZGEgb3 BlcmF0ZXMg aW4gb3Zlci A4MCBjb3Vu dHJpZXMgYW 5kIGNvbnRp bnVlcyB0by BleHBhbmQg aXRzIHByZX NlbmNlIGlu IGVtZXJnaW 5nIG1hcmtl dHMsIHBhcn RpY3VsYXJs eSBpbiBBc2 lhIGFuZCBM YXRpbiBBbW VyaWNhLjxi cj42LiBTdH JhdGVnaWMg cGFydG5lcn NoaXBzIGFu ZCBhY3F1aX NpdGlvbnM6 IFRha2VkYS Bjb2xsYWJv cmF0ZXMgd2 l0aCBvdGhl ciBwaGFybW FjZXV0aWNh bCBjb21wYW 5pZXMgYW5k IHJlc2Vhcm NoIGluc3Rp dHV0aW9ucy B0byBkZXZl bG9wIG5ldy B0cmVhdG1l bnRzIGFuZC B0ZWNobm9s b2dpZXMuIF RoZSBjb21w YW55IGFsc2 8gYWNxdWly ZXMgb3RoZX IgY29tcGFu aWVzIHRvIG V4cGFuZCBp dHMgcHJvZH VjdCBwb3J0 Zm9saW8gYW 5kIGdlb2dy YXBoaWMgcm VhY2guPGJy PjcuIFBhdG llbnQtY2Vu dHJpYyBhcH Byb2FjaDog VGFrZWRhIG ZvY3VzZXMg b24gdW5kZX JzdGFuZGlu ZyBwYXRpZW 50cycgbmVl ZHMgYW5kIH dvcmtzIHRv IGRldmVsb3 AgdHJlYXRt ZW50cyB0aG F0IG1lZXQg dGhvc2Ugbm VlZHMuIFRo ZSBjb21wYW 55IGFsc28g aW52ZXN0cy BpbiBwYXRp ZW50IGVkdW NhdGlvbiBh bmQgYWNjZX NzIHByb2dy YW1zIHRvIG 1ha2UgdHJl YXRtZW50cy Btb3JlIGFj Y2Vzc2libG UgdG8gdGhv c2UgaW4gbm VlZC48YnI+ T3ZlcmFsbC wgVGFrZWRh J3MgYnVzaW 5lc3MgbW9k ZWwgaXMgY2 VudGVyZWQg b24gaW5ub3 ZhdGlvbiwg c3RyYXRlZ2 ljIHBhcnRu ZXJzaGlwcy wgYW5kIGEg cGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoIHRvIGJy aW5nIGxpZm UtY2hhbmdp bmcgbWVkaW NpbmVzIHRv IHBlb3BsZS Bhcm91bmQg dGhlIHdvcm xkLg==
Interesting facts about the company
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVz hVeWd5Y2dj ekVBMVhsRE 5nNjIud2Vi cCIgYWx0PS JUYWtlZGEg UGhhcm1hY2 V1dGljYWwi IHRpdGxlPS JUYWtlZGEg UGhhcm1hY2 V1dGljYWwi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgVGFrZWRh IFBoYXJtYW NldXRpY2Fs PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TliBH ZXQgaW5zaW dodHMgZnJv bSA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IG5v dyEKICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDE2cHg7 IGZvbnQtc2 l6ZTogMTRw eDsgY29sb3 I6ICM0NDQ7 IGZvbnQtZm FtaWx5OiAt YXBwbGUtc3 lzdGVtLCBC bGlua01hY1 N5c3RlbUZv bnQsIFNlZ2 9lIFVJLCBS b2JvdG8sIE hlbHZldGlj YSBOZXVlLC BzYW5zLXNl cmlmOyBsaW 5lLWhlaWdo dDogMS42Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BIYXZlIHlv dSBoZWFyZC BhYm91dCBv dXIgc2hvcn QgPHN0cm9u ZyBzdHlsZT 0nZm9udC13 ZWlnaHQ6ID YwMDsnPkRh aWx5IFZpZG VvIE5ld3Ns ZXR0ZXI8L3 N0cm9uZz4/ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dodHRwczov L3d3dy5pbn NpZ2h0ZnVs dmFsdWUuY2 9tL25ld3Ns ZXR0ZXIucG hwJyB0YXJn ZXQ9J19ibG Fuaycgc3R5 bGU9J2NvbG 9yOiAjMDA3 QkZGOyB0ZX h0LWRlY29y YXRpb246IG 5vbmU7IGZv bnQtd2VpZ2 h0OiA1MDA7 IG1hcmdpbi 1sZWZ0OiA2 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BGaW5kIG91 dCBtb3JlCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 E+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg CiAgICAgIC AgCiAgICAg ICAgPHNwYW 4gY2xhc3M9 J2JsdXJyZW QtdGV4dCc+ CiAgICAgIC AgICAgIE1T NGdWR0ZyWl cgUmhJRkJv WVhKdCBZV0 5sZFhScFky IEZzSUdsek lHRWcgU21G d1lXNWxjMi BVZ2JYVnNk R2x1IFlYUn BiMjVoYkMg QndhR0Z5Yl dGaiBaWFYw YVdOaGJDIE JqYjIxd1lX NTUgTENCb1 pXRmtjWCBW aGNuUmxjbV ZrIElHbHVJ RlJ2YTMgbH ZMQ0JLWVhC aCBiaTRnU1 hRZ2FYIE1n YjI1bElHOW 0gSUhSb1pT QnNZWCBKbl pYTjBJSEJv IFlYSnRZV0 5sZFggUnBZ MkZzSUdOdi BiWEJoYm1s bGN5IEJwYm lCMGFHVWcg ZDI5eWJHUW dZbiBrZ2Nt VjJaVzUxIF pTNDhZbkkr TWkgNGdWR2 hsSUdOdiBi WEJoYm5rZ2 QyIEZ6SUda dmRXNWsgWl dRZ2FXNGdN VCBjNE1TQm llU0JEIGFH OWlaV2tnVk cgRnJaV1Jo SUVrZyBZVz VrSUhkaGN5 IEJwYm1sMG FXRnMgYkhr Z1kyRnNiRy BWa0lGUmhh MlZrIFlTQk RhRzlpWlcg a2dVR2hoY2 0xaCBZMlYx ZEdsallXIH dnVTJodmND NGcgU1hRZ2 QyRnpJRyBF Z2MyMWhiR3 dnIGNHaGhj bTFoWTMga2 dhVzRnUkc5 eiBhRzl0WV dOb2FTIHdn VDNOaGEyRX MgSUVwaGNH RnVMaiB4aW NqNHpMaUJV IFlXdGxaR0 VnVUcgaGhj bTFoWTJWMS BkR2xqWVd3 Z1ltIFZqWV cxbElHRWcg Y0hWaWJHbG pJRyBOdmJY QmhibmtnIG FXNGdNVGsw T1MgQmhibV FnZDJGeiBJ R3hwYzNSbF pDIEJ2YmlC MGFHVWcgVk c5cmVXOGdV MyBSdlkyc2 dSWGhqIGFH RnVaMlV1UE cgSnlQalF1 SUZSaCBhMl ZrWWVLQW1Y IE1nYldGcG JpQm0gYjJO MWN5QnBjeS BCeVpYTmxZ WEpqIGFDQm hibVFnWkcg VjJaV3h2Y0 cxbCBiblFn YVc0Z2RHIG hsSUdacFpX eGsgY3lCdl ppQnZibSBO dmJHOW5lU3 dnIFoyRnpk SEp2WlcgNT BaWEp2Ykc5 biBlU3dnWV c1a0lHIE5s Ym5SeVlXd2 cgYm1WeWRt OTFjeSBCem VYTjBaVzBn IFpHbHpiM0 prWlggSnpM aUJKZENCaC BiSE52SUhC eWIyIFIxWT JWeklIWmgg WTJOcGJtVn pJRyBGdVpD QnZkbVZ5IE xYUm9aUzFq YjMgVnVkR1 Z5SUcxbCBa R2xqWVhScG IyIDV6TGp4 aWNqNDEgTG lCVWFHVWdZ MiA5dGNHRn VlU0JvIFlY TWdZU0JuYk cgOWlZV3dn Y0hKbCBjMl Z1WTJVc0lI IGRwZEdnZ2 IzQmwgY21G MGFXOXVjeS BCcGJpQnZk bVZ5IElEZ3 dJR052ZFcg NTBjbWxsY3 lCaCBibVFn Y21WbmFXID l1Y3l3Z2FX NWogYkhWa2 FXNW5JSCBS b1pTQlZibW wwIFpXUWdV M1JoZEcgVn pMQ0JGZFhK diBjR1VzSU dGdVpDIEJC YzJsaExqeG kgY2o0Mkxp QlVZVyB0bF pHRWdhR0Z6 IElHRWdjM1 J5YjIgNW5J R052YlcxcC BkRzFsYm5R Z2RHIDhnYz NWemRHRnAg Ym1GaWFXeH BkSCBrZ1lX NWtJSGRoIG N5QnNhWE4w WlcgUWdhVz RnZEdobCBJ RVJ2ZHlCS2 IyIDVsY3lC VGRYTjAgWV dsdVlXSnBi RyBsMGVTQk pibVJwIFky VnpJR1p2Y2 kgQXhNU0Jq YjI1eiBaV0 4xZEdsMlpT IEI1WldGeW N5NDggWW5J K055NGdTVy A0Z01qQXdP Q3dnIFZHRn JaV1JoSUcg RmpjWFZwY2 1WayBJRTFw Ykd4bGJtID VwZFcwZ1VH aGggY20xaF kyVjFkRyBs allXeHpMQ0 JoIElHeGxZ V1JwYm0gY2 dZbWx2Y0do aCBjbTFoWT JWMWRHIGxq WVd3Z1kyOX QgY0dGdWVT Qm1iMiBOMW MyVmtJRzl1 IElIUm9aU0 JrWlggWmxi Rzl3YldWdS BkQ0J2WmlC dmJtIE52Yk c5bmVTQjAg Y21WaGRHMW xibiBSekxq eGljajQ0IE xpQlVZV3Rs WkcgRWdhWE 1nYVc1MiBi MngyWldRZ2 FXIDRnZG1G eWFXOTEgY3 lCd1lYSjBi bSBWeWMyaH BjSE1nIFlX NWtJR052Yk cgeGhZbTl5 WVhScCBiMj V6SUhkcGRH IGdnYjNSb1 pYSWcgY0do aGNtMWhZMi BWMWRHbGpZ V3dnIFkyOX RjR0Z1YVcg VnpMQ0JoWT JGayBaVzFw WXlCcGJuIE 4wYVhSMWRH bHYgYm5Nc0 lHRnVaQyBC eVpYTmxZWE pqIGFDQnZj bWRoYm0gbD ZZWFJwYjI1 eiBManhpY2 o0NUxpIEJV YUdVZ1kyOX QgY0dGdWVT QmhiSCBOdk lHaGhjeUJo IElITjBjbT l1WnkgQm1i Mk4xY3lCdi BiaUJwYm01 dmRtIEYwYV c5dUlHRnUg WkNCcGJuWm xjMyBSeklH aGxZWFpwIG JIa2dhVzRn Y20gVnpaV0 Z5WTJnZyBZ VzVrSUdSbG RtIFZzYjNC dFpXNTAgTG lCSmJpQXlN RCBJd0xDQn BkQ0J6IGNH VnVkQ0J2ZG 0gVnlJQ1Ew SUdKcCBiR3 hwYjI0Z2Iy IDRnVWlaRU xqeGkgY2o0 eE1DNGdWRy BGclpXUmhJ R2hoIGN5Qm hJSEpwWTIg Z2dhR2x6ZE c5eSBlU0Jo Ym1RZ2FHIE Z6SUhCc1lY bGwgWkNCaE lITnBaMiA1 cFptbGpZVz UwIElISnZi R1VnYVcgNG dkR2hsSUdS bCBkbVZzYj NCdFpXIDUw SUc5bUlIUm 8gWlNCd2FH RnliVyBGal pYVjBhV05o IGJDQnBibV IxYzMgUnll U0JwYmlCSy BZWEJoYmk0 Z1NYIFFnYU dGeklHSmwg Wlc0Z2NtVm piMiBkdWFY cGxaQ0IzIG FYUm9JRzUx YlcgVnliM1 Z6SUdGMyBZ WEprY3lCaG JtIFFnYUc5 dWIzSnogSU c5MlpYSWdk RyBobElIbG xZWEp6IExq eGljajR4TV MgNGdWR0Zy WldSaCBJR2 hoY3lCaElH IE52Y25Cdm NtRjAgWlNC d2FHbHNiMy BOdmNHaDVJ R05oIGJHeG xaQ0JVWVcg dGxaR0V0YV hOdCBMQ0Iz YUdsamFDIE JsYlhCb1lY TnAgZW1Wek lIUm9aUyBC amIyMXdZVz U1IDRvQ1pj eUJqYjIgMX RhWFJ0Wlc1 MCBJSFJ2SU hCaGRHIGxs Ym5SekxDQm wgYlhCc2Iz bGxaWCBNc0 lHRnVaQ0J6 IGIyTnBaWF I1TGogeGlj ajR4TWk0Zy BWR2hsSUdO dmJYIEJoYm 5rZ2FHRnog SUdaaFkyVm tJRyBOb1lX eHNaVzVuIF pYTWdhVzRn Y20gVmpaVz UwSUhsbCBZ WEp6TENCcG JtIE5zZFdS cGJtY2cgY0 dGMFpXNTBJ RyBWNGNHbH lZWFJwIGIy NXpJR0Z1Wk MgQnNaV2Ro YkNCcCBjM0 4xWlhNZ2Nt IFZuWVhKa2 FXNW4gSUhO dmJXVWdiMi BZZ2FYUnpJ RzFsIFpHbG pZWFJwYjIg NXpMaUJJYj NkbCBkbVZ5 TENCcGRDIE JqYjI1MGFX NTEgWlhNZ2 RHOGdZbSBV Z1lTQnRZV3 B2IGNpQndi R0Y1WlggSW dhVzRnZEdo bCBJR2RzYj JKaGJDIEJ3 YUdGeWJXRm ogWlhWMGFX TmhiQyBCdF lYSnJaWFF1 IFBHSnlQak V6TGkgQkpi aUF5TURJeC BMQ0JVWVd0 bFpHIEVnWV c1dWIzVnUg WTJWa0lHbD BjeSBCcGJu UmxiblJwIG IyNGdkRzhn WW0gVmpiMj FsSUdFZyBa Mnh2WW1Gc0 lHIHhsWVdS bGNpQnAgYm lCeVlYSmxJ RyBScGMyVm hjMlZ6IElI ZHBkR2dnWV MgQm5iMkZz SUhSdiBJR3 hoZFc1amFD IEF6TUNCeV lYSmwgSUdS cGMyVmhjMi BVZ2RHaGxj bUZ3IGFXVn pJR0o1SUQg SXdNekF1UE dKeSBQakUw TGlCVVlXIH RsWkdFZ2FY TWcgWVd4em J5QnJibSA5 M2JpQm1iM0 lnIGFYUnpJ SE4wY20gOX VaeUJqYjNK dyBiM0poZE dVZ1kzIFZz ZEhWeVpTQm ggYm1RZ2FH RnpJRyBKbF pXNGdjbVZq IGIyZHVhWH BsWkMgQmhj eUJ2Ym1VZy BiMllnZEdo bElIIGR2Y2 14azRvQ1og Y3lCdGIzTj BJRyBGa2JX bHlaV1FnIF kyOXRjR0Z1 YVcgVnpJR0 o1SUVadiBj blIxYm1VZ1 RXIEZuWVhw cGJtVWcgWm 05eUlERXdJ RyBOdmJuTm xZM1YwIGFY WmxJSGxsWV ggSnpManhp Y2o0eCBOUz RnU1c0Z1lX IFJrYVhScG IyNGcgZEc4 Z2NHaGhjbS AxaFkyVjFk R2xqIFlXeH pMQ0JVWVcg dGxaR0VnYV hNZyBZV3h6 YnlCcGJuIF p2YkhabFpD QnAgYmlCMl lYSnBiMyBW eklHOTBhR1 Z5IElHSjFj Mmx1WlggTn paWE1zSUds dSBZMngxWk dsdVp5IEJt YjI5a0lIQn kgYjJSMVkz UnpMQyBCb1 pXRnNkR2dn IFlXNWtJR0 psWVggVjBl U0J6ZFhCdy BiR1Z0Wlc1 MGN5IHdnWV c1a0lHMWwg WkdsallXd2 daRyBWMmFX TmxjeTQ9Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
Takeda Pharmaceutical

πŸ“Š Get full analytics about Takeda Pharmaceutical

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal